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The Effects of Methylphenidate on Neural Substrates  
Associated with Interference Suppression in Children  
with ADHD: A Preliminary Study Using Event Related fMRI
ObjectiveaaThe core deficit of attention deficit hyperactivity disorder (ADHD) is associated 
with frontal cortex and related circuitry. Children with ADHD and a medication history have 
shown atypical brain activation in prefrontal and striatal brain regions during cognitive chal-
lenge. We investigated two cognitive control operations such as interference suppression (IS) 
and response inhibition (RI) in children with ADHD. We also assessed the brain functions affect-
ed by the methylphenidate (MPH) effect by comparing the blood-oxygen level dependent 
(BOLD) signals in ADHD children on and off medication. 
MethodsaaEight children (9-11 years of age) with combined-type ADHD underwent rapid 
event-related functional magnetic resonance imaging (fMRI) during performance of a modified 
flanker task. Two fMRI (3.0 T) scans were conducted with a one week interval-one with MPH 
treatment and the other without. Functional maps were generated through group averaging and 
performance-based correlational analyses. 
ResultsaaPerformances of the two cognitive control operations did not differ significantly 
between on-MPH and off-MPH status other than the reaction time to incongruent stimuli in 
ADHD children. In those affected by MPH treatment, an increased activation in the right pre-
frontal cortex during incongruent task was observed relative to a neutral trial in children with 
ADHD.
ConclusionaaOn the treatment of MPH, the ADHD children exhibited increased activation 
of the right frontal cortex during interference suppression. This finding suggested that MPH 
affected the right frontal cortex in ADHD compensating for a reduced level of interference 
suppression. Future studies will be required to ascertain the MPH effect of cognitive brain re-
gions among large number of children with ADHD.
   Psychiatry Investig 2010;7:49-54
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Introduction
Attention deficit hyperactivity disorder (ADHD) is the most common developmental dis-
order of childhood,
1 and its various cognitive and behavioral manifestations can be explained 
by a deficit in the frontal cortex and related circuitry.
2 Several cognitive models have proposed 
that reduced response inhibition (RI) is a cardinal symptom of ADHD.
1 Cognitive control, 
the ability to voluntary constrain actions in a goal-directed manner, comprises at least two op-
erations, RI and interference suppression (IS). Measured by error of commission on cue-
guided tasks in the inhibition of a prepotent response, RI is reduced in subjects with ADHD.
3,4 
Similarly, IS, which can be measured by erroneous or slower responses to target stimulus 
due to of interference from competing responses, is also reduced in subjects with ADHD.
5 
However, neural substrates of reduced cognitive control in ADHD are not yet fully understood. 50  Psychiatry Investig 2010;7:49-54
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Generally, when children grow into adolescences, RI and 
IS improve
6,7 in accordance with myelination and synaptic 
organization,
8,9 and in accordance with functional activation 
of the frontal cortex.
10,11 However, children with ADHD show 
delayed or abnormal maturation of the frontal cortex and re-
lated circuitry leading to inefficient cognitive control behav-
iors.
4 Methylphenidate (MPH), used as the first line therapy 
for ADHD patients, is known to significantly improve cogni-
tive control function with respect to RI; however, with only 
minimal effect on IS.
5
Structural MRI studies have demonstrated abnormally re-
duced right frontal lobes,
11 as well as similarly affected stria-
tal
12 and cerebellar
13 structures in ADHD subjects. Causal mo-
dels of ADHD have long implicated dysfunction in the fronto-
striatal networks supporting executive function, a hypothesis 
that can be examined systematically using functional neuro-
imaging.
12,14 Previous functional imaging studies in the course 
of the go/no-go have shown abnormalities in frontal lobe ac-
tivation in children and adolescents with ADHD.
4 Addition-
ally, children with ADHD together with their medication his-
tory have shown atypical brain activation in prefrontal and 
striatal brain regions during cognitive challenge.
15 To the best 
of our knowledge, few studies have been done in children 
with ADHD in Korea using fMRI. In this study, we investi-
gated the neural basis of two cognitive control operations, IS 
and RI, among children with ADHD. We also assessed the 
brain regions affected by the MPH effect by comparing the 
blood-oxygen level dependent (BOLD) signals in ADHD 
children either on or off medication.
Methods
Subjects
This study was conducted in eight right handed ADHD boys 
(age: 10.3±1.3, elementary school 4-6th grade) who exhibited 
a good treatment response to MPH. All patients were put into 
the ADHD category according to DSM-IV
16 and the ADHD 
Rating Scale-IV (ARS)17 after interviews with child and ado-
lescent psychiatrist. Diagnoses were confirmed by another psy-
chiatrist according to Kiddie Schedules for Affective Disorder 
and Schizophrenia-Present and Lifetime version (KSADS-
PL).
18 Exclusion criteria were those under an IQ of 85 as per the 
Wechsler Intelligence Scale for Children (K-WISC-III) test,
19 
and those who had history or evidence of neurological disorders 
or Axis 1 psychiatric disorders. Study objectives and methods 
were fully explained to recruited patients and parents and ver-
bal assent and written consent were obtained. 
If needed, prior to MRI scan, an explanation of the proce-
dures and equipment used in fMRI was provided. Fees for two 
fMRI scanning were paid by the investigators. This study 
protocol was approved by the Institutional Review Board (IRB) 
of Chung Ang University Hospital, South Korea. 
Task procedure
The first MRI scan was performed while the patients were 
medicated, and the second MRI scan was done after the med-
ication had been intentionally discontinued for 1 week as pre-
viously suggested by Shafritz et al.
20 and Zang et al.
21 Every 
attempt was made to maintain general clinical treatment set-
tings. Patients were instructed to take their medication at 8 a.m. 
and the fMRI was performed at 2 p.m. when the maximum 
concentration had been attained. Five ADHD patients were 
taking Concerta
® (27-45 mg) and other three others were tak-
ing Metadate CD
® (30-40 mg). Both fMRI scans were per-
formed at the same time of day. The subjects viewed the pro-
jected, computer-controlled paradigm on a screen at the head 
of the scanner via a 45° angled mirror, affixed to the MRI head 
coil. They used their right hand to hold a button and responded 
by pressing it with their index and middle fingers. To minimi-
ze head movement, memory form fit to each subject was used. 
Subjects performed two runs of a modified Eriksen flanker 
task
 (Figure 1)6 using E-prime (Psychology Software Tools, 
Pittsburgh, PA, USA). Each trial consisted of a display com-
prised of a central arrow with two flanking stimuli on either 
side. Subjects were instructed to press one of two buttons in-
dicating the direction of the central arrow (left/right) while ig-
noring the flanking stimuli. On congruent and incongruent tri-
als, the flankers were arrows pointing in the same or different 
directions, respectively in relation to the central arrow. On 
neutral trials, the flankers were diamonds that were not associ-
ated with a response. On no-go trials, the flanking stimuli sig-
nals were Xs, indicated that subjects should have withheld 
their response. Trials were presented in a rapid event-related 
design
10 with a 3-second intertrial interval. In each trial, the dis-
play (800 msec) was followed by a blank screen (300 msec) 
and then a fixed stimulus (1600 msec); intertrial interval was 
300 msec. Subjects practiced about 40 times for about 2 min-
utes prior to conducting the actual test, which consisted of 
252 trials all of which took 12 minutes and 36 seconds.
Imaging procedure
Prior to the MRI scans, a subject’s head was fixed and con-
firmed as to whether the subject could see the screen. A 3-T 
MRI (Philips Achieva 3.0T X-series) was used to acquire T1-
weighted flow compensated spin-echo anatomical images 
(TR=500 msec; minimum TE) in 16 contiguous 7-mm axial 
slices, parallel to the plane of the anterior commissure-posteri-
or commissure. Functional acquisition included the same sli-
ces with a T2*-sensitive gradient echo spiral pulse sequence 
with parameters of TR=1,000 msec, TE=30 msec, a field of 
view=23 cm, a flip angle=90° and an 80×80 matrix.
Data analysis
Using SPM2 (Wellcome Department of Cognitive Neurol-
ogy, London, UK), images were corrected for differences in     YS Lee et al. 
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slice acquisition time and motion. All subjects displayed less 
than 1 mm of motion in x, y, and z directions throughout the co-
urse of each scan. Images were normalized into a standard 
space
22 and interpolated to 2×2×2 mm cubic voxels. Nor-
malized image volumes were spatially smoothed (8-mm full 
width at half-maximum Gaussian kernel) and temporally fil-
tered (low-pass filter: 4-msec Gaussian; high-pass filter: cal-
culated on the basis of trial frequency). fMRI responses were 
modeled using a canonical hemodynamic response function. 
For each subject, activation maps were generated using linear 
contrasts identifying regions that were more active during in-
congruent relative to neutral trials and during no-go relative 
to neutral trials. All analyses were generated by using a vox-
el-level height threshold of p<0.05 uncorrected for multiple 
comparisons as well as a spatial extent threshold of 30 voxels. 
Results
Demographic and clinical characteristics of subjects are 
shown in Table 1. The ARS score of subjects at baseline was 
36.2±8.3 (inattention 19.8±3.2, hyperactivity-impulsivity 
16.3±5.9) and Clinical Global Scale-Severity (CGI-S) was 
over 4 (4.5±0.8). After three months of treatment, those with 
CGI-S and CGI-improvement (CGI-I) scores less than 2 were 
defined as good responders and were included in this study. 
The ARS score for on-MPH was 20.7±9.5 (inattention 11.3 
±5.7, hyperactivity-impulsivity 9.3±4.3) and that for off-
MPH was 28.3±8.2 (inattention 15.0±5.4, hyperactivity-im-
pulsivity 13.3±3.5). There were no significant differences in 
cognitive data during the modified Eriksen flanker task be-
tween on and off MPH, including reaction time of congruent 
stimuli and accuracy rate on go/no-go tasks. But there was a 
significant difference in the reaction time of incongruent stim-
uli between on and off treatment (p=0.01). Average MPH dos-
es during first scan was 34.2±7.5 mg/day for Concerta
® and 
36.7±5.8 mg/day for Metadate CD
®. 
As seen Table 2 and Figure 2, ADHD children exhibited ac-
tivation of the right frontal lobe, and in particular, the superi-
Table 1. Demographic and clinical characteristics of subjects with ADHD children
Mean±SD
Age 010.3±1.30
IQ 117.1±15.1
    Verbal IQ 116.5±21.7
    Non verbal IQ 113.8±5.60
On-drug Off-drug p value
ARS*
    Total 0020.7±9.50 028.3±8.20 0.173
    Inattention 0011.3±5.70 015.0±5.40 0.293
    Hyperactivity-impulsivity 0009.3±4.30 013.3±3.50 0.141
Performance on the modified flaker test  
    Reaction time (congruent) (msec) 0554.0±34.8 531.4±29.4 0.101
    Reaction time (incongruent) (msec)† 600.91±27.5 567.8±33.9 0.001
    Reaction time (no go) (msec) 0535.9±70.4 510.4±58.0 0.249
    Accuracy on the “go” task (%) 0078.6±12.4 075.6±21.5 0.367
    Accuracy on the “no-go” task (%) 0092.8±8.10 093.4±10.3 0.192
*Korean ADHD Rating Scale-parent version, †p<0.01. ADHD: attention deficit hyperactivity disorder, SD: standard deviation, IQ: inter-
quartile
Table 2. Regional activation during interference suppression (incongruent versus neutral trials) in ADHD children on and off treatment
Region Brodmann’s area Number of voxels
Talairach coordinates
Z score
x y z
Right frontal lobe
    Superior frontal gyrus* 8 40 34 26 52 3.53
    Precentral gyrus* 76 48 10 08 3.45
    Middle frontal gyrus* 46 76 50 22 24 3.40
    Inferior frontal gyrus† 76 50 16 18 2.70
*Uncorrected p<0.001, †Uncorrected p<0.005. ADHD: attention deficit hyperactivity disorder52  Psychiatry Investig 2010;7:49-54
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or frontal gyrus (Brodmann’s area 8), precentral gyrus, middle 
frontal gyrus (Brodmann’s area 46), and inferior frontal gyrus, 
at a significance threshold of uncorrected p<0.001 or 0.005 du-
ring incongruent relative to neutral trial while undergoing 
MPH treatment. There were no significant differences in neu-
ral correlates of RI between on and off MPH.
Discussion
This study was an fMRI pilot study conducted in 4-6th 
grade elementary school children using an event-related de-
sign. The authors believe this study to be the first fMRI study 
conducted in Korean children with ADHD using such a de-
sign. From the study results, the suppression of the interfer-
ing response was associated with an increased activation of 
the right frontal lobe in medicated ADHD children. This find-
ing suggested that MPH affected the activation of the right 
frontal cortex, which correlates with improvement of IS dur-
ing cognitive challenge. 
Vaidya et al.
23 reported that ADHD patients lacked right 
frontal lobe activation during RI and exhibited decreased ac-
tivity of the left inferior frontal lobe during IS. Further, Bush 
et al.
24 reported decreased cingulate cortex activity and atypi-
cal fronto-striatal activity during IS in adults with ADHD. Se-
veral studies
25,26 have also reported that ADHD children ex-
hibit relatively decreased fronto-striatal activity compared to 
other normal children. However, some studies have also report-
ed increased activity or no difference.
4 These controversial 
findings may stem from differences in the event-related para-
digm. In a recent study, Bush et al.
27 reported increases in the 
activity of the dorsal anterior midcingulate cortex, right dor-
solateral prefrontal cortex, and both parietal lobes in adult AD-
HD patients on OROS MPH for 6 weeks. Also, during IS, AD-
HD patients are known to show atypical activation of the fron-
tal lobe and caudate nucleus when compared to normal control 
group.
23 In this study, altered activation of the caudate nucleus 
was not found; however, decreased activity of the frontal lobe 
was observed when MPH was discontinued as compared to 
when patients were on MPH. In particular, when subjects were 
on MPH, greater activation of the frontal lobe was observed 
during IS than when neutral stimulus was given (Figure 2). 
The authors could conclude that MPH has an effect on the 
right frontal lobe during IS test which corresponds with the re-
sults of Bush et al.27; however, changes in the right frontal lobe 
activity during an RI task with MPH administration were not 
seen in this study. 
Scheres et al.
5 reported that MPH had an affect on response 
time of RI rather than on IS and that this affect was unrelated 
to dose. On the other hand, in this study, only response time sig-
nificantly different between on and off MPH during IS, a find-
ing which is in contrast to previous studies. Further, although 
medication was discontinued for a week, considering inconsis-
tent cognitive data with previous studies, the residual effect of 
long term medication treatment cannot be excluded. Finally, a 
dose-response relationship was not verified in this study. 
In the current study, subjects exhibited symptomatic impro-
vements with MPH; however, improved executive function of 
the frontal lobe was not observed except for the response time 
of IS. Further, MPH-induced increases in frontal lobe activity 
were identical to those in previous studies.
23,28 Several studi-
es
10,29 have reported that the lateral frontal lobe may be the cen-
ter for interference control in adults. This study replicated pre-
vious study results and suggested the possibility of concluding 
that MPH can normalize ADHD’s cognitive control center. 
But unlike Bush et al.’s results,
24,27 decreased activity in the ante-
rior cingulate in adult with ADHD during IS was not observed. 
The dopamine system affect on the fronto-sriatal network,
12 
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Figure 1. Example of a modified Eriksen flanker task. Each trial 
consisted of a display comprising a central arrow and two flanking 
stimuli on either side. Subjects were instructed to press one of two 
buttons indicating the direction of the central arrow (left/right) while 
ignoring the flanking stimuli. On congruent and incongruent trials, 
the flankers were arrows pointing in the same or different direction 
respectively in relation to the central arrow. On neutral trials the flan-
kers were diamonds that were not associated with a response. On 
no-go trials, the flanking stimuli signaled were Xs that subjects 
should withhold their response.
Figure 2. Neural correlates of interference suppression during in-
congruent relative to neutral trials between children with ADHD on 
MPH treatment. Images show region of more activation during in-
congruent relative to neutral trials on MPH treatment. For regions 
positively correlated with improved interference suppression, un-
corrected p<0.005. ADHD: attention deficit hyperactivity disorder, 
MPH: methylphenidate.
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as related to the RI model, can be activated by MPH treatme-
nt; however, this activated fronto-striatal network alone can-
not fully explain improved IS. The role of the parieto-temporal 
network in IS improvement is also important.
30,31 Unlike pre-
vious studies,
5,32 the effect of MPH related to IS as opposed to 
RI was observed in this study. 
Comprehensive results from the previous fMRI studies us-
ing event-related designs on cognitive controls
25,30,33 have re-
vealed the activation of widespread regions of the frontal cor-
tex during RI. Particularly striking is the predominance of ri-
ght-hemisphere activation, especially within the inferior fron-
tal region. Recently, Bush et al.
27 focused on changes in the ri-
ght frontal lobe activity during IS in adults with ADHD on 
medication. This study also revealed increased right frontal 
lobe activity similar to that of healthy children during incon-
gruent stimulus while being treated with MPH. 
This study was limited in that it utilized a sample size that 
was too small to generalize the relationship between MPH and 
increased activity of the right frontal lobe. Further studies uti-
lizing a larger sample size are needed. Moreover, there was no 
normal control group for head-to-head comparisons. A second 
limitation was that subjects were recruited from a population 
that had been undergoing treatment in clinical practice. That 
was why the second MRI scan was done one week after dis-
continuation of medication. However, it was impossible to 
completely exclude the possibility of a residual effect of long-
term medication. Thus in further studies, drug-naïve patients 
should be selected for such studies and the first MRI should be 
performed prior to medication initiation and a subsequent 
MRI can proceed after the initiation of medication. 
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